Pirarubicin-loaded PLGA Nanoparticle Synthesis
Corresponding Organization :
Other organizations : Osaka Medical and Pharmaceutical University
Variable analysis
- Amount of PLGA (#B6017–1 50:50 DL-PLG, Corefront, Inc.)
- Amount of pirarubicin (Sigma-Aldrich)
- Incorporation of pirarubicin into PLGA nanoparticles
- Incorporation of rhodamine-labeled pirarubicin into PLGA nanoparticles
- Acetone solvent
- 2% polyvinyl alcohol (PVA)/distilled water mixture
- Ultrasonic wave power level of 1.0 (Sonicator 3000, Misonix Inc.)
- Stirring time of 16 h to evaporate the acetone
- Centrifugation at 200 RCF for 10 minutes
- Centrifugation at 15000 RCF for 30 minutes
- 3 times washing with distilled water
- Addition of PBS and homogenization at 10,000 rpm for 10 minutes
- Freeze-drying using a lyophilizer (VD-550R, TAITEC, Tokyo, Japan) for over 48 h
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!